Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 108Lymphoma, Large B-Cell, Diffuse 97Lymphoma 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Non-Hodgkin 37Lymphoma, Follicular 37Burkitt Lymphoma 36Leukemia 30Multiple Myeloma 29Lymphoma, Mantle-Cell 26Hodgkin Disease 25Lymphoma, T-Cell, Peripheral 20Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Large-Cell, Anaplastic 15Lymphoma, B-Cell, Marginal Zone 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Neoplasm Metastasis 13Lymphoma, B-Cell 13Leukemia, Lymphocytic, Chronic, B-Cell 12Recurrence 11Neoplasms, Plasma Cell 11Immunoblastic Lymphadenopathy 11Lymphoma, T-Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Neoplasms 7Enteropathy-Associated T-Cell Lymphoma 7Waldenstrom Macroglobulinemia 5Primary Myelofibrosis 5Myasthenia Gravis 5

Interventions

Dexamethasone 29Aprepitant 24Palonosetron 20Ondansetron 20Calcium Dobesilate 13Olanzapine 12Granisetron 11Therapeutics 7fosaprepitant 6Doxorubicin 6Cyclophosphamide 6dexamethasone acetate 5netupitant 4Vincristine 4dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Metoclopramide 3Lorazepam 3Dronabinol 3Acupressure 3peppermint oil 2netupitant, palosentron drug combination 2ginger extract 2dexamethasone 21-phosphate 2Sugars 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nausea × Prednisone × Clear all
NCT00651755 2013-07-02

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled 14 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡